Cogent Biosciences's total assets for Q3 2024 were $384.02M, a decrease of -10.68% from the previous quarter. COGT total liabilities were $69.36M for the fiscal quarter, a 22.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.